BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8093220)

  • 1. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.
    Owens RJ; Rose JK
    J Virol; 1993 Jan; 67(1):360-5. PubMed ID: 8093220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
    Johnson JE; Rodgers W; Rose JK
    Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
    Johnson JE; Schnell MJ; Buonocore L; Rose JK
    J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein.
    Whitt MA; Buonocore L; Prehaud C; Rose JK
    Virology; 1991 Dec; 185(2):681-8. PubMed ID: 1660200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles.
    Schubert M; Joshi B; Blondel D; Harmison GG
    J Virol; 1992 Mar; 66(3):1579-89. PubMed ID: 1310767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
    Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfation of the human immunodeficiency virus envelope glycoprotein.
    Bernstein HB; Compans RW
    J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R5 HIV env and vesicular stomatitis virus G protein cooperate to mediate fusion to naive CD4+ T Cells.
    Pace MJ; Agosto L; O'Doherty U
    J Virol; 2011 Jan; 85(1):644-8. PubMed ID: 20980513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity.
    Owens RJ; Burke C; Rose JK
    J Virol; 1994 Jan; 68(1):570-4. PubMed ID: 8254774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein.
    Oomens AG; Megaw AG; Wertz GW
    J Virol; 2003 Mar; 77(6):3785-98. PubMed ID: 12610153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
    Zhang XY; La Russa VF; Reiser J
    J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.
    Kahn JS; Schnell MJ; Buonocore L; Rose JK
    Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
    Yu D; Wang W; Yoder A; Spear M; Wu Y
    PLoS Pathog; 2009 Oct; 5(10):e1000633. PubMed ID: 19851458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
    Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
    J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.
    Berlioz-Torrent C; Shacklett BL; Erdtmann L; Delamarre L; Bouchaert I; Sonigo P; Dokhelar MC; Benarous R
    J Virol; 1999 Feb; 73(2):1350-61. PubMed ID: 9882340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
    Bartz SR; Vodicka MA
    Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.